Windrose Medical Properties Trust Prices Equity Offering

INDIANAPOLIS, April 12  /PRNewswire-FirstCall/ -- Windrose Medical Properties Trust (NYSE:WRS), a self-managed specialty medical properties REIT, announced today it has priced a public offering of 2,300,000 common shares at $14.80 per share. As part of the offering, Windrose granted its underwriters a 30-day option to purchase up to an additional 345,000 shares to cover over-allotments. The net proceeds of the offering, after underwriting discounts, commissions and estimated offering expenses, and before giving effect to the over-allotment option, if exercised, will be approximately $32.3 million. The proceeds will be used to pay down Windrose's existing indebtedness and for general corporate purposes, including possible future acquisitions of specialty medical properties.

Robert W. Baird & Co. was sole-book runner and Raymond James & Associates, Inc. was co-manager.

The closing of the offering is expected to occur on April 18, 2006 and is subject to customary closing conditions.

Copies of the prospectus supplement relating to the offering may be obtained by contacting Robert W. Baird & Co. Incorporated, 777 East Wisconsin Avenue, Milwaukee, WI 53201.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale or an offer to buy these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.

ABOUT WINDROSE

Windrose is a self-managed Real Estate Investment Trust (REIT) based in Indianapolis, Indiana with offices in Nashville, Tennessee. Windrose was formed to acquire, selectively develop and manage specialty medical properties, such as medical office buildings, ambulatory surgery centers, outpatient treatment and diagnostic facilities and specialty hospitals and treatment centers.

SAFE HARBOR

Some of the statements in this news release, including those related to this offering and the use of proceeds, constitute forward-looking statements. Such statements include, in particular, statements about our beliefs, expectations, plans and strategies that are not based on historical facts. You should not rely on our forward-looking statements because the matters they describe are subject to known and unknown risks, uncertainties, assumptions and changes in circumstances, many of which are beyond our control, which may cause our actual results to differ significantly from those expressed in any forward-looking statement. The factors that could cause actual results to differ materially from current expectations include our ability to complete this offering, our ability to deploy the net proceeds from the offering, changes in economic and general business conditions and other factors described from time to time in filings we make with the Securities and Exchange Commission. The forward-looking statements contained herein represent our judgment as of the date hereof, and we caution readers not to place undue reliance on such statements. We do not undertake to publicly update or revise any forward-looking statement whether as a result of new information, future events or otherwise.

  Contact:
   Windrose Medical Properties Trust
   Fred Farrar
   President and COO
   317-860-8213

  Investors/Media:
   The Ruth Group
   Stephanie Carrington/Jason Rando
   646 536-7017/7025
   
   

DATASOURCE: Windrose Medical Properties Trust



CONTACT:  Fred Farrar, President and COO of Windrose Medical Properties

Trust, [phone]; or Investors: Stephanie Carrington, [phone],

, or Media: Jason Rando, [phone],

, both of The Ruth Group, for Windrose Medical

Properties Trust

Copyright